USPH · NYSE · Medical - Care Facilities

U.S. Physical Therapy (USPH)

Outpatient physical therapy chain that scales by keeping local clinicians as co-owners.

$83.50
vs last close+1.05 (+1.27%)
Loading prices…

U.S. Physical Therapy, Inc.USPH
Health Care

Operator of 780 outpatient physical and occupational therapy clinics across 44 states, paired with an on-site industrial injury prevention segment. Growth is driven by majority-stake acquisitions of clinician-owned practices, with founders retaining a minority share — an ownership model the company has used as its primary expansion engine since the 1990s.

Outpatient physical and occupational therapy through 780 clinics in 44 states forms the core business. A second segment, Industrial Injury Prevention, delivers on-site ergonomics, occupational health, and sports medicine at over 600 employer locations nationwide through subsidiary Briotix Health.

Growth runs through majority-stake joint ventures with local clinician-founders, who typically retain a minority ownership share. That retained equity ties operator incentives to clinic performance, and USPH provides the capital, payor relationships, and back-office infrastructure.

Reimbursement flows primarily from Medicare and private payors; Medicare therapy-services thresholds and targeted review requirements are a standing structural constraint. The company has paid a quarterly cash dividend continuously since 2011.

Company facts

CEOChristopher J. Reading
ListedMay 28, 1992
ExchangeNYSE
HeadquartersHouston, TX
CountryUnited States
Employees7,294
CIK0000885978
ISINUS90337L1089

Market cap$1.25B
EPS (ttm)$0.1700
P/E (ttm)485.00
ROE-1.3%
P/B2.80
P/S1.61
Dividend yieldDiv yield2.22%
Beta0.64vs XLV 0.54

Price target$90.00+9.2%Average of 13 analysts
ConsensusBuy10 of 13 analysts
Ratings

Target rangeAs of Sep 21, 2026

Latest analyst notes

DateFirmActionPriorCurrent
May 13, 2026BarringtonTarget
Target: $98
Target: $90
Mar 9, 2026JefferiesTarget
Target:
Target: $102
Dec 16, 2024B of A SecuritiesUpgrade
Rating: Neutral
Rating: Buy
Oct 7, 2024B of A SecuritiesDowngrade
Rating: Buy
Rating: Neutral

Next report
Nov 4, 26
in 43 days
EPS estimate
$0.76
Revenue estimate
$214.5M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$0.65$0.48$0.81$0.66$0.67$0.46$0.75Pending
Estimate$0.69$0.46$0.71$0.67$0.67$0.55$0.81$0.76
Surprise−5.8%+4.3%+14.1%−1.5%0.0%−16.4%−7.9%

RevenueReportedEstimate

Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$180.4M$152.5M$164.2M$164.0M$202.7M$198.3M$214.1MPending
Estimate$173.1M$188.2M$189.9M$200.1M$199.9M$200.9M$211.4M$214.5M
Surprise+4.2%−18.9%−13.5%−18.0%+1.4%−1.3%+1.3%
Estimate$0.76
ReportedDue Nov 4, 2026
Estimate$214.5M
ReportedDue Nov 4, 2026
View details

Debt to equity86.00%
Current ratio127.10%

ProfitabilityRevenueNet incomeNet margin

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$168.0M$180.4M$152.5M$164.2M$164.0M$202.7M$198.3M$214.1M
Net income$5.5M$7.4M$9.9M$8.8M$7.2M−$10.5M−$4.3M$1.6M
Net margin3.3%4.1%6.5%5.4%4.4%0.0%0.0%0.7%

GrowthOperating income

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Operating income$14.7M$14.5M$19.6M$24.9M$25.3M$22.0M$14.9M$21.9M
YoY growth−7.1%Turned profit+31.6%+60.2%+71.8%+51.4%−23.9%−12.0%

Balance sheet, Jun 30, 2026Cash & short-term investments $24.9M · Total debt $385.8M · Total assets $1.25B · Shareholders' equity $448.7M

Revenue
$214.1M
Operating income
$21.9M
Net income
$1.6M
View details

Dividend yield
2.22%
Next ex-date
Nov 21, 26
estimated · in 60 days
Annual dividend
$1.83
per share
Schedule
Quarterly
4 payments a year

HistoryDividendAnnual yield

Nov '24Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26
Dividend$0.44$0.45$0.45$0.45$0.45$0.46$0.46$0.46
Annual yield1.96%2.31%2.41%2.05%2.57%2.36%2.94%2.34%
Ex-dateNov 15Mar 14May 23Aug 22Nov 17Mar 13May 22Aug 21
Payment dateDec 6Apr 11Jun 13Sep 12Dec 12Apr 10Jun 12Sep 11
View details

Institutions109.46%16.34M shares
222 holders · as of Jun 30, 2026
Insiders2.52%375.4K shares
15 holders · as of Sep 15, 2026
Adds to111.98%

14.92M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

These groups come from separate filings that can overlap, so they add to 111.98%; nothing is left for Other.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
BlackRock, Inc.Institution
15.17%2.26Mas of Jun 30, 2026
T. Rowe Price Associates, Inc.Institution
8.30%1.24Mfiled Feb 14, 2022
Bahl & Gaynor IncInstitution
5.77%861,574as of Jun 30, 2026
Kayne Anderson Rudnick Investment Management LLCInstitution
5.67%846,674as of Jun 30, 2026
Copeland Capital Management, LLCInstitution
5.64%841,544as of Jun 30, 2026

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Sep 11, 2026Peter Francis Minandirector+5$79.00
Jun 12, 2026Peter Francis Minandirector+1$66.50
Jun 8, 2026Peter Francis Minandirector+492$63.14
Jun 9, 2026Peter Francis Minandirector+288$61.50
Mar 11, 2026Graham D. Reeveofficer: COO−662$78.86
View details

  • Concentra

    Largest US occupational health network; competes on workers’ comp PT and onsite

  • Encompass Health

    Largest US inpatient rehab hospital operator, upstream in the rehab continuum

  • The Pennant Group

    Home health and hospice provider competing on in-home PT for post-acute rehab

Compare

CompanyPriceChange
U.S. Physical Therapy$83.50+1.27%$1.25B485.026.71.6+30.4%
Concentra$35.26+1.39%$4.45B22.620.41.9+10.0%
Encompass Health$124.01+2.02%$12.06B19.819.41.9+9.6%
The Pennant Group$39.84+2.26%$1.35B43.327.41.2+35.8%
Median22.620.41.9+10.0%